Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Novavax Stock Quote

Novavax (NASDAQ: NVAX)

$3.99
(-3.2%)
-$0.13
Price as of April 16, 2024, 4:00 p.m. ET

Novavax Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
NVAX -55.02% -61.18% -17.24% -95%
S&P +22.34% +74.52% +11.78% +719%

Novavax Company Info

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

News & Analysis

The Fool has written over 1,000 articles on Novavax.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.